Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 5:11:842.
doi: 10.3389/fphar.2020.00842. eCollection 2020.

Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019)

Lixin Ke  1 , Cuncun Lu  2 , Rui Shen  1 , Tingting Lu  2 , Bin Ma  3 , Yunpeng Hua  1
Affiliations

Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019)

Lixin Ke et al. Front Pharmacol. .

Abstract

Background: Drug-induced liver injury (DILI) is a common adverse event, which compromises the safety of numerous drugs, poses a significant risk to patient health, and enhances healthcare expenditures. Many articles have been recently published on DILI related research, though no relevant scientometric study has been published yet. This scientometric study was aimed at comprehensively analyzing the knowledge base and emerging topics on DILI.

Methods: The articles and reviews related to DILI, published from 2010 to 2019 in the Web of Science Core Collection (WoSCC), were retrieved on March 15, 2020, using relevant keywords. Four different scientometric software (HistCite, VOSviewer, CiteSpace, and R-bibliometrix) was used to conduct this scientometric study.

Results: A total of 1,995 publications were retrieved (including 1,550 articles and 445 reviews) from 592 academic journals with 56,273 co-cited references in 10 languages by 2,331 institutions from 79 countries/regions. The majority of publications (n = 727, 36.44%) were published in the United States, and the University of North Carolina contributed the most publications (n = 89, 4.46%). The most productive academic journal on DILI was the Toxicological Sciences [n = 79, 3.96%; impact factor (IF) 2018 = 3.564], and Hepatology was the first co-cited journal (n = 7,383, IF 2018 = 14.971). Fontana RJ and Teschke R may have significant influence on DILI research, with more publications (n = 46; n = 39) and co-citations (n = 382; n = 945). Definition, incidence rate or clinical characteristics, etiology or pathogenesis (such as the character of the innate immune system, the regulation of cell-death pathways, and susceptible HLA-B*5701 genotype), identification of main drugs and causality assessment (criteria and methods) were the knowledge base for DILI research. Exploring the microscopic mechanism (such as the organelle dysfunction and cytotoxicity induced by drugs, and exploration of role of neutrophils in DILI using mouse models) and developed newer approaches to prevent DILI (such as the prospective HLA-B*5701 screening and in vitro approaches for assessing the potential risk of candidate drugs for DILI) were the recent major topics for DILI research.

Conclusion: This scientometric study comprehensively reviewed the publications related to DILI during the past decade using quantitative and qualitative methods. This information would provide references for scholars, researching on DILI.

Keywords: CiteSpace; HLA-B*5701; VOSviewer; drug-induced liver injury; scientometric.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Annual output of drug-induced liver injury (DILI) research (A) and the linear fitting of publication growth in DILI research (B).
Figure 2
Figure 2
The regional distribution (A) and the network map of countries (B, T = 5) related to drug-induced liver injury (DILI) research.
Figure 3
Figure 3
The network map of institutions for drug-induced liver injury (DILI) research (T = 17).
Figure 4
Figure 4
The network map of academic journals (A, T = 21) and co-cited academic journals (B, T=700) for drug-induced liver injury (DILI) research.
Figure 5
Figure 5
The dual-map overlay of journals related to drug-induced liver injury (DILI) research.
Figure 6
Figure 6
The network map of authors (A, T = 17) and co-cited authors (B, T = 230) related to drug-induced liver injury (DILI) research.
Figure 7
Figure 7
The network map of co-citation references for drug-induced liver injury (DILI) research (T = 125).
Figure 8
Figure 8
Top 16 references with strong citation burstiness (MD = 5). The red bars mean some references cited frequently; the blue bars were references cited infrequently.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aithal G. P., Watkins P. B., Andrade R. J., Larrey D., Molokhia M., Takikawa H., et al. (2011). Case definition and phenotype standardization in drug-induced liver injury. Clin. Pharmacol. Ther. 89 (6), 806–815. 10.1038/clpt.2011.58 - DOI - PubMed
    1. Andrade R. J., Lucena M. I., Fernández M. C., Pelaez G., Pachkoria K., García-Ruiz E., et al. (2005). Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129 (2), 512–521. 10.1016/j.gastro.2005.05.006 - DOI - PubMed
    1. Andrade R. J., Ortega-Alonso A., Lucena M. I. (2016). Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge. Expert Opin. Drug Metab. Toxicol. 12 (6), 589–593. 10.1517/17425255.2016.1141896 - DOI - PubMed
    1. Aria M., Cuccurullo C. (2017). bibliometrix: An R-tool for comprehensive science mapping analysis. J. Informetr. 11 (4), 959–975. 10.1016/j.joi.2017.08.007 - DOI
    1. Bénichou C. (1990). Criteria of drug-induced liver disorders. Report of an international consensus meeting. J. Hepatol. 11 (2), 272–276. 10.1016/0168-8278(90)90124-a - DOI - PubMed